Relmada Therapeutics RLMD
NASDAQ RLMD
$3.73 -0.06 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) FCF Margin (2012 - 2013)

Updated

Relmada Therapeutics' FCF Margin came in at -196.12% for FY2013, down 100.86 percentage points from -95.27% in FY2012.

Analysis

Relmada Therapeutics (RLMD) FCF Margin (2012 - 2013) Analysis & Trends

  • Per Business Quant, earlier years put FCF Margin at -95.27% in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Relmada Therapeutics 404.28 Mn 404.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2013 -493.19%
Feb 28, 2013 327.32%
Nov 30, 2012 69.66%
Aug 31, 2012 -220.73%
May 31, 2012 -496.50%
API Access

Relmada Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEY